SEARCH RESULTS FOR: "Tag: REGN"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(3)
2018(6)
2017(22)
2016(17)
2015(12)
CATEGORIES
5-Minute Market Rundown(1)
Analyst Downgrades(1)
Analyst Update(4)
Analyst Upgrades(3)
Best and Worst Stocks(5)
Buzz Stocks(10)
By the Numbers(4)
Earnings Preview(1)
Editor's Pick(2)
Expectational Analysis(3)
General(5)
Indexes and ETFs(2)
Intraday Option Activity(5)
Market Recap(1)
Midday Market Check(3)
Opening View(5)
Quantitative Analysis(4)
Stock Market News(6)
Stocks On the Move(13)
Technical Analysis(2)
Regeneron Pharmaceuticals Stock Retreats After Asthma Antibody Data
https://www.schaeffersresearch.com/content/news/2019/06/21/regeneron-pharmaceuticals-stock-retreats-after-asthma-antibody-data
6/21/2019 9:45 AM
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is moving lower this morning, last seen down 0.9% at $317.63, even after the drugmaker revealed positive topline results from a Phase 2 study of its IL-33 a...
Regeneron Pharmaceuticals Set to Test Chart Support After Earnings
https://www.schaeffersresearch.com/content/news/2019/05/07/regeneron-pharmaceuticals-set-to-test-chart-support-after-earnings
5/7/2019 9:22 AM
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) stock is trading down 3.7% ahead of the bell, after the biotech reported slimmer-than-expected first-quarter adjusted earnings of $4.45 per share. Regeneron...
2 Healthcare Stocks Soaring On Fresh "Buy" Ratings
https://www.schaeffersresearch.com/content/news/2019/01/04/2-healthcare-stocks-soaring-on-fresh-buy-ratings
1/4/2019 3:03 PM
Stocks are finishing the week out strong today, powered by the latest comments from Fed Chair Jerome Powell. Among the notable climbers today are healthcare stock Varian Medical Systems, Inc. (NYSE:V...
Regeneron Stock Gains After Goldman's "Buy" Recommendation
https://www.schaeffersresearch.com/content/news/2018/12/14/regeneron-stock-gains-after-goldmans-buy-recommendation
12/14/2018 10:02 AM
The shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) are up 0.9% to trade at $381.87, after Goldman Sachs upgraded its rating on the stock to "buy" from "neutral," adding it to its Conviction Bu...
Tinder Lights Match Stock on Fire; Plus, Should Celgene Pull a Tesla?
https://www.schaeffersresearch.com/content/news/2018/08/08/tinder-lights-match-stock-on-fire-plus-should-celgene-pull-a-tesla
8/8/2018 2:54 PM
Stocks are a mixed bag today, with the Dow lower thanks to Disney (DIS), while the Nasdaq heads toward its seventh straight win. Biotech Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is struggling, bu...
Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.
More About
Schaeffer's
Contact
Us
Partner Center